A phosphorylation‑independent monoclonal antibody improves detection of TDP‑43 pathology across frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and limbic predominant age related TDP‑43 encephalopathy neuropathological change
Journal of Neuropathology & Experimental Neurology · 06.08.2026
DOI: 10.1093/jnen/nlag085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 06.08.2026. Verfasst von Xiaojing Zheng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, P.R. China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Drug Discovery Foundation, Alzheimer’s Drug Discovery Foundation.
Abstract (Originalsprache)
TDP-43 proteinopathies encompass frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), amyotrophic lateral sclerosis (ALS-TDP), and limbic predominant age related TDP-43 encephalopathy neuropathological change (LATE-NC). These proteinopathies exhibit subtype-specific aggregate architectures that may constrain epitope accessibility in situ. We compared a phosphorylation-independent monoclonal antibody targeting a C-terminal epitope (MAb No. 9) with the phospho-specific pSer409/410 antibody to determine whether its signal relates to regional neurodegeneration in a multicenter autopsy cohort spanning FTLD-TDP types A-C, ALS-TDP, and Alzheimer disease neuropathologic change (ADNC) with or without LATE-NC. Immunolabeling with MAb No. 9 detected pathological TDP-43 across all diagnostic groups with enhanced labeling of dystrophic neurites and thread/dot-like pathology in FTLD-TDP types A/B and in ALS-TDP. MAb No. 9 performance was equivalent to p409/410 in FTLD-TDP type C. In ADNC with stage 3 LATE-NC, MAb No. 9 revealed a greater limbic burden and labeled both α type and β type inclusions. Dual label immunofluorescence demonstrated strong spatial overlap with p409/410 but additionally highlighted fine punctate pathology. MAb No. 9 burden in FTLD-TDP type A correlated strongly with cortical neurodegeneration but showed weaker and variable associations, particularly in severely atrophic cortex. These findings indicate that filament architecture governs C-terminal epitope accessibility and that MAb No. 9 may be a complementary tool for subtype refinement, clinicopathologic correlation and translational biomarker development in TDP-43 proteinopathies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, P.R. China.
- Department of Pathology, University of Utah, Salt Lake City, UT, United States.
- Department of Pathology, University of Kentucky, Lexington, KY, United States.
- Department of Pathology, University of Pittsburgh, Pittsburgh, PA, United States.
- Epigenomics and Computational Biology Lab, Fralin Life Sciences Institute, Virginia Tech, Blacksburg, VA, United States.
ORCID-Profile: Qinwen Mao
Förderung
- NIA NIH HHS
- Alzheimer's Drug Discovery Foundation
- Alzheimer’s Drug Discovery Foundation
- National Institute on Aging
Zitieren
APA
Zheng, X., Zhang, N., Wang, L., Zhao, H., Liu, C., Wang, J., Zhao, W., Zhao, J., Yang, P., Robinson, L., Hunt, L., Lokken, A., Lin, L., Nelson, P. T., Kofler, J., Xie, H., Xia, H., & Mao, Q. (2026). A phosphorylation‑independent monoclonal antibody improves detection of TDP‑43 pathology across frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and limbic predominant age related TDP‑43 encephalopathy neuropathological change. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlag085
Vancouver
Zheng X, Zhang N, Wang L, Zhao H, Liu C, Wang J, et al. A phosphorylation‑independent monoclonal antibody improves detection of TDP‑43 pathology across frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and limbic predominant age related TDP‑43 encephalopathy neuropathological change. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlag085
BibTeX
@article{Zheng2026,
author = {Zheng, Xiaojing and Zhang, Ning and Wang, Lixia and Zhao, Hongjuan and Liu, ChengGang and Wang, Jiayu and Zhao, Wanli and Zhao, Junli and Yang, Peiyan and Robinson, Lorraina and Hunt, Lindsay and Lokken, Alex and Lin, Leo and Nelson, Peter T and Kofler, Julia and Xie, Hehuang and Xia, Haibin and Mao, Qinwen},
title = {A phosphorylation‑independent monoclonal antibody improves detection of TDP‑43 pathology across frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and limbic predominant age related TDP‑43 encephalopathy neuropathological change},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlag085}
}
EUVIMED